Who Is Responsible for Rising Drug Costs?
February 5, 2016
An analysis by the National Center for Policy Analysis concludes more competition and less regulation are needed to drive drug prices down.
Devon Herrick writes:
Americans’ prescription drug bills are rising. Most drugs are affordable, but prices for a few drugs exceed the average mortgage payment. They can be especially costly when there are only one, two or three patented drugs in a given therapeutic class. Drug makers are free to establish whatever price they believe the market will bear and, depending on the number of competitors, they could have significant pricing power.
Download Herrick's full report.
Image via Thinkstock
Author
Devon Herrick, Ph.D., worked for the National Center for Policy Analysis (NCPA) until it ceased operations in July 2017. He is a policy advisor to The Heartland Institute.
media@heartland.org
@DevonHerrick
